Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18–26 years in China: a randomised blinded clinical trial

作者：Fengcai Zhu, Guo‐Hua Zhong, Weijin Huang, Kai Chu, Li Zhang, Zhaofeng Bi, Kongxin Zhu, Qi Chen, Tingquan Zheng, Minglei Zhang, Sheng Liu, Jin‐Bo Xu, Hongxing Pan, Guang Sun, Feng-Zhu Zheng, Qiu-Fen Zhang, Xiu-Mei Yi, Sijie Zhuang, Shoujie Huang, Huirong Pan, Yingying Su, Ting Wu, Jun Zhang, Ningshao Xia · 发表于：The Lancet Infectious Diseases · 年份：2023 · DOI：10.1016/s1473-3099(23)00275-x · 被引用次数：45 · 研究领域：Cervical Cancer and HPV Research、Immunotherapy and Immune Responses、Herpesvirus Infections and Treatments